Suven Pharmaceuticals Q1 Results
- BSE: 543064
- NSE: SUVENPHAR
- ISIN: INE03QK01018
- Sector: Biotechnology & Drugs
BSE
1,133.05
-2.70 (-0.24%)
-2.70 (-0.24%)Volume8.97 K
Updated: Tue 18 Mar, 2025 | 15:52:55
NSE
1,133.75-1.40 (-0.12%)
-1.40 (-0.12%)Volume1.92 L
Updated: Tue 18 Mar, 2025 | 15:40:37
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Suven Pharmaceuticals Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 24 | Mar 24 | QoQ Comp | Jun 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 230.69 | 252.93 | -8.79% | 347.55 | -33.62% |
| Selling/ General/ Admin Expenses Total | 45.62 | 45.77 | -0.32% | 28.74 | 58.71% |
| Depreciation/ Amortization | 13.40 | 17.41 | -23.04% | 12.54 | 6.85% |
| Other Operating Expenses Total | 14.46 | 5.12 | 182.28% | 16.21 | -10.77% |
| Total Operating Expense | 164.16 | 194.46 | -15.58% | 193.13 | -15.00% |
| Operating Income | 66.53 | 58.47 | 13.79% | 154.42 | -56.92% |
| Net Income Before Taxes | 83.09 | 70.85 | 17.27% | 163.94 | -49.32% |
| Net Income | 60.77 | 53.37 | 13.86% | 120.59 | -49.61% |
| Diluted Normalized EPS | 2.39 | 2.20 | 8.86% | 4.74 | -49.58% |